spacer
spacer

PDBsum entry 4nsh

Go to PDB code: 
protein ligands links
Hydrolase PDB id
4nsh

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chain
129 a.a.
Ligands
DMS ×3
ACT ×3
QPT ×2
SO4
Waters ×65
PDB id:
4nsh
Name: Hydrolase
Title: Carboplatin binding to hewl in 0.2m nh4so4, 0.1m naac in 25% peg 4000 at ph 4.6
Structure: LysozymE C. Chain: a. Synonym: 1,4-beta-n-acetylmuramidasE C, allergen gal d iv. Ec: 3.2.1.17
Source: Gallus gallus. Bantam,chickens. Organism_taxid: 9031
Resolution:
2.10Å     R-factor:   0.199     R-free:   0.262
Authors: S.W.M.Tanley,K.Diederichs,L.M.J.Kroon-Batenburg,C.Levy, A.M.M.Schreurs,J.R.Helliwell
Key ref: S.W.Tanley et al. (2014). Carboplatin binding to histidine. Acta Crystallogr F Struct Biol Commun, 70, 1135-1142. PubMed id: 25195881 DOI: 10.1107/S2053230X14016161
Date:
28-Nov-13     Release date:   15-Oct-14    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chain
Pfam   ArchSchema ?
P00698  (LYSC_CHICK) -  Lysozyme C from Gallus gallus
Seq:
Struc:
147 a.a.
129 a.a.
Key:    PfamA domain  Secondary structure  CATH domain

 Enzyme reactions 
   Enzyme class: E.C.3.2.1.17  - lysozyme.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: Hydrolysis of the 1,4-beta-linkages between N-acetyl-D-glucosamine and N-acetylmuramic acid in peptidoglycan heteropolymers of the prokaryotes cell walls.

 

 
DOI no: 10.1107/S2053230X14016161 Acta Crystallogr F Struct Biol Commun 70:1135-1142 (2014)
PubMed id: 25195881  
 
 
Carboplatin binding to histidine.
S.W.Tanley, K.Diederichs, L.M.Kroon-Batenburg, C.Levy, A.M.Schreurs, J.R.Helliwell.
 
  ABSTRACT  
 
Carboplatin is a second-generation platinum anticancer agent used for the treatment of a variety of cancers. Previous X-ray crystallographic studies of carboplatin binding to histidine (in hen egg-white lysozyme; HEWL) showed the partial conversion of carboplatin to cisplatin owing to the high NaCl concentration used in the crystallization conditions. HEWL co-crystallizations with carboplatin in NaBr conditions have now been carried out to confirm whether carboplatin converts to the bromine form and whether this takes place in a similar way to the partial conversion of carboplatin to cisplatin observed previously in NaCl conditions. Here, it is reported that a partial chemical transformation takes place but to a transplatin form. Thus, to attempt to resolve purely carboplatin binding at histidine, this study utilized co-crystallization of HEWL with carboplatin without NaCl to eliminate the partial chemical conversion of carboplatin. Tetragonal HEWL crystals co-crystallized with carboplatin were successfully obtained in four different conditions, each at a different pH value. The structural results obtained show carboplatin bound to either one or both of the N atoms of His15 of HEWL, and this particular variation was dependent on the concentration of anions in the crystallization mixture and the elapsed time, as well as the pH used. The structural details of the bound carboplatin molecule also differed between them. Overall, the most detailed crystal structure showed the majority of the carboplatin atoms bound to the platinum centre; however, the four-carbon ring structure of the cyclobutanedicarboxylate moiety (CBDC) remained elusive. The potential impact of the results for the administration of carboplatin as an anticancer agent are described.
 

 

spacer

spacer